Dr. Whelan Provides a MA.20 Trial Result Summary

Lead study investigator Timothy J. Whelan, BM, BCh, professor of Oncology and the division head of Radiation Oncology at McMaster University and the Juravinski Cancer Centre, Hamilton, Ontario, explains that the results from his NCIC-CTG MA.20 intergroup phase III trial demonstrated that women with breast cancer that have 1-3 positives nodes after breast conserving surgery, usually receiving whole breast irradiation, will benefit from the addition of regional radiation to their treatment.